Volume 1, Issue 1 (11-2017)                   GMJ Medicine 2017, 1(1): 15-20 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tabibzadeh Dezfuli S A, Ehsani M, Lakzaei Azar O. Carvacrol Alleivated Negative Effects of Diabetes on Inflammation and Oxidation by Modulation in Gene Expression of Inflammatory and Antioxidant System in Diabetic Rat Model. GMJ Medicine. 2017; 1 (1) :15-20
URL: http://gmjpress.de/article-1-28-en.html
1- Assistant Professor, Trauma and Emergency Medicine Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
2- Department of Microbiology, Faculty of Basic Sciences, Lahijan Branch, Islamic Azad University (IAU), Lahijan, Iran
3- Young Researchers and Elite Club, Lahijan Branch, Islamic Azad University, Lahijan, Iran
Abstract:   (464 Views)
Background: Diabetes has been known as a prevalence disorder and the use of common drugs has been faced many issues with multiple limitations. This study aimed to evaluate the use of carvacrol, as a novel agent, for treatment of diabetes.
Methods: A single dose of streptozotocin (55mg/kg body weight) was used to induce the diabetes in rats. The animals were grouped into five groups including 1) Control healthy animals, 2) Diabetic controls, 3, 4 & 5) Diabetic animals given carvacrol (5, 10 and 15 mg/kg body weight/day) in neutral sterile olive oil solution oral gavage, respectively. The levels of malondialdehyde (MDA) and catalase, superoxide dismutase (SOD) and glutathione peroxidase (GPX) activities were evaluated. The levels of IL-1β, IL-6 and TNF-α expression in liver were assessed.
Results: Administration of streptozotocin increased levels of MDA, IL-1β, IL-6 and TNF-α and also decreased activities of catalase, SOD and GPX (P<0.05). Oral administration of carvacrol, especially 15 mg/kg body weight/day, could decrease levels of MDA, IL-1β, IL-6 and TNF-α and also increase activities of catalase, SOD and GPX in comparison to diabetic control (P<0.05).
Conclusion: Carvacrol could decrease or alleviate the negative effects of carvacrol on inflammation and antioxidant status that could be attributed to antioxidant properties. It could be recommended to apply carvacrol in commercial prescription in combination with other agents or as a single agent for treatment of diabetes. 
Full-Text [PDF 838 kb]   (152 Downloads) |   |   Full-Text (HTML)  (188 Views)  
Type of Study: Original Article | Subject: Pharmacology
Received: 2017/09/12 | Accepted: 2017/11/5 | Published: 2017/11/25

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2019 All Rights Reserved | GMJ Medicine